Kristin Eivindvik

Kristin Eivindvik is the current Chief Development Officer at PCI Biotech. Kristin has over 20 years of experience in the healthcare industry, having worked for companies such as GE Healthcare, Alertis Medical, and Nycomed Imaging / Amersham Health / GE Healthcare. Throughout their career, Kristin has held various positions, with their last role being Project Director. Kristin is a highly experienced and skilled individual who has been able to successfully navigate their way through the ever-changing healthcare landscape.

Kristin Eivindvik has a Masters of Science in Pharmacy from the University of Oslo and also went to Fagerborg Videregående Skole in Oslo.

Some of their coworkers include Ludovic Robin - Chief Business Officer, Amir Snapir - Chief Medical Officer, and Ronny Skuggedal - CFO. Kristin Eivindvik reports to Per Walday, CEO.